Alexion Commences Dosing in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PN... (ngth of URL please copy and paste into ....)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> TECHNOLOGY

Alexion Commences Dosing in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan

Date:1/7/2008

ngth of URL, please copy and paste into

browser window.)

(2) Hillmen P, Young NS, Schubert J, et al. The complement inhibitor

eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med.

2006;355:1233-1243.

(3) Hill A, Platts PJ, Smith A et al. The incidence and prevalence of

paroxysmal nocturnal hemoglobinuria (PNH) and survival of patients in

Yorkshire [abstract]. Blood. 2006;108(11):985.

(4) Socie G, Mary J Yves, de Gramont A, et al. Paroxysmal nocturnal

haemoglobinuria: long-term follow-up and prognostic factors. Lancet

1996; 348:573-577.

(5) Parker C, Omine M, Richards S, et al. Diagnosis and management of

paroxysmal nocturnal hemoglobinuria. Blood. 2005;106:3699-3709.

(6) Hillmen P. Lewis SM, Bessler M, Luzzatto L, Dacie JV. Natural history

of paroxysmal nocturnal hemoglobinuria. N Engl J Med 1995; 333:1253-

1258.

(7) Johnson RJ, Hillmen P. Paroxysmal nocturnal hemoglobinemia: Nature's

gene therapy? J Clin Path: Mol Pathol. 2002;55:145-152.

(8) Wang, et al. Clinical significance of a minor population of

paroxysmal nocturnal hemoglobinuria-type cells in bone marrow failure

syndrome. Blood 2002;100:3897-3902.

(9) Iwanga, et al. Paroxysmal nocturnal haemoglobinuria clones in

patients with myelodysplastic syndromes. Brit J Haem. 1998; 102:465-

474.

(10) Maciejewski, et al. Relationship between bone marrow failure

syndromes and the presence of glycophosphatidyl inositol-anchored

protein-deficient clones. Brit J Haem. 2001;115:1015-1022.

(11) Hill A, Richards S, Hillmen P. Recent developments in the

understanding and management of paroxysmal nocturnal haemoglobinuria.

British Journal of Haematology 2007; 137:3, 181-192.

SOURCE Alexion Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6
Related medicine technology :

1. EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer
2. Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
3. Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV
4. Sunesis Pharmaceuticals Commences Clinical Trials of SNS-595 and SNS-314
5. Sinovac Commences Vaccination on Volunteers for Phase II Clinical Trial on Pandemic Influenza H5N1 Vaccine
6. Memory Pharmaceuticals Commences Phase 1 Clinical Program for R4996/MEM 63908
7. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain
8. Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
9. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Mildly Infected Diabetic Foot Ulcers
10. MDS Patients on Five-Day Vidaza(R) Dosing Schedules Achieve Transfusion Independence Consistent with Seven-day Schedule
11. VioQuest Pharmaceuticals Announces Dosing of First Patient in Phase IIa Solid Tumor Study for Lenocta(TM), a Novel Protein Tyrosine Phosphatase Inhibitor

Post Your Comments:

(Date:11/25/2009)...LOVELAND, Colo., Nov. 25 ...rovider of advanced diagnostic and specialty pro...agreements with Roche Diagnostics Corporation for ...nsumables for the veterinary market. ,, (Log...HESKALOGO ) ,, "Heska and Roche share the same ...

(Date:11/25/2009)...INCETON, N.J., Nov. 25 P... pharmaceutical company committed to discovering, ...t viral infections, reported financial results for...ember 30, 2009 Pharmasset held $58.4 million in ca...,, Pipeline Update and 2009 Highlights ,, ...

(Date:11/25/2009)...CAGO and STAFA, Switzerland, Nov. 25 /PRNewswire/ ...acturer of innovative hearing solutions, presented... Conference, focusing on the special needs of the ...leading experts in aging and audiology from around...veryday with older people with hearing loss for an...

[0] Heska Announces Supply Agreement With Roche Diagnostics [0] Pharmasset Reports Fiscal Year End 2009 Financial Results [0] Phonak Successfully Hosts Hearing Care for Adults 2009 Conference

..., Belgium, March 28, 2007,/PRNewswire-FirstCall/ -... results of a sample collection study aimed at,ide...aid in the,assessment for risk of sepsis progressi...d therapeutic options. Clinical investigator,Eman...or of,research at the department of emergency medi...

...3, the World,s First Commercial Vaccine,for Travel...ly,Completes Phase I Clinical Trials , ,Trial conf... , ODENSE, Denmark, March 28, 2007 -ACE BioScience...to announce the successful,completion of Phase I c...world,s first commercial vaccine for Travellers,D...

Other Medicine Technology:Biosite Reports on Presentation of Preliminary Data From Sepsis,Program 2 Biosite Reports on Presentation of Preliminary Data From Sepsis,Program 3 Biosite Reports on Presentation of Preliminary Data From Sepsis,Program 4 Biosite Reports on Presentation of Preliminary Data From Sepsis,Program 5 Ace Biosciences, Ace393, the World's First Commercial Vaccine for,Travellers' Diarrhoea Caused by Campylobacter Successfully,Completes Phase I Clinical Trials 2 Ace Biosciences, Ace393, the World's First Commercial Vaccine for,Travellers' Diarrhoea Caused by Campylobacter Successfully,Completes Phase I Clinical Trials 3 Ace Biosciences, Ace393, the World's First Commercial Vaccine for,Travellers' Diarrhoea Caused by Campylobacter Successfully,Completes Phase I Clinical Trials 4

Biosite Reports on Presentation of Preliminary Data From Sepsis,Program Ace Biosciences, Ace393, the World's First Commercial Vaccine for,Travellers' Diarrhoea Caused by Campylobacter Successfully,Completes Phase I Clinical Trials

(Date:11/27/2009)...e/ - Uploadable USB pedometers may be new, but the...ination of advanced accelerometer functionality an...ncern over the accuracy of self-reported data. It,...oved participation in a fitness program. ,, Cor...suppliers to integrate this technology. "Our healt...

(Date:11/27/2009)...ov. 27 Team Garmin-Slipstream, the...d to ethical sporting and developing the next gene...it will become Team Garmin-Transitions with the ad...the team. Transitions Optical is the world,s leadi...most advanced photochromic technology in the wides...

(Date:11/27/2009)...27 Allrecipes.com , the world,s...raffic numbers, with more than 2.8 million visitor...icture of what was served on the biggest food holi...2009 weighed in at 2,225 calories per serving, a 5...g to the Allrecipes site, Sweet Potato Pie I sto...

(Date:11/26/2009)... -- With cold and flu season upon us, it,s more im...rol the spread of infections and avoid illness. ,...elves healthy, but to avoid transmitting illness i...ertified in infection-control), nursing director f...spital for Special Surgery (HSS) in Manhattan. ,...

(Date:11/26/2009)...nal rollercoaster, study finds , , THURS...factor meets the jubilant sports fan. , A new s...who root for the winning team -- enjoy the greates...nd victory was in doubt, producing feelings of wor...giving weekend as you,re glued to the TV set, watc...

Breaking Medicine News(10 mins):Health News:New USB technology adds accountability and convenience to wellness programs 2 Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2 Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3 Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2 Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3 Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 4 Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2 Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3 Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4 Health News:Watching the Nail-Biting Big Game Hurts So Good 2 Health News:Watching the Nail-Biting Big Game Hurts So Good 3

[0] New USB technology adds accountability and convenience to wellness programs [0] Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor [0] It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories [1] Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use [0] Watching the Nail-Biting Big Game Hurts So Good

...SAN FRANCISCO, Calif., Jan. 30 Onmark, a leading,...ommunity-based practices,and a McKesson Specialty ...ted Quality (IQ) Program with the goal of helping ... Lynx,Mobile(TM) technology platform, helps practi...

...TER, Pa., Jan. 30 Members of Highmark,s,FreedomBl...njoy increased,health care options. Effective imme...es will be covered at Heart of Lancaster and Lanca... with Medicare in,the surrounding areas," said J. ...

..., Ohio, Jan. 30 STERIS Corporation,(NYSE: STE ) ...008 third,quarter ended December 31, 2007. Fiscal ... million compared with $299.0 million in the third... compared with net income of $21.3 million, or $0....

...port predicts obesity could cost state an addition...y by 2020, EAGAN, Minn., Jan. 30 Less than one q...ight by 2020 according to a new,report issued by B...A Portrait of Two Minnesotas, highlights the fact ...

...SAN FRANCISCO, Calif., Jan. 30 Anesiva,Inc. (Nasd...ompleted the,hiring and deployment of its hospital...roduction of Anesiva,s FDA-approved Zingo(TM) (lid...team with substantial,hospital sales experience to...

...L, Wash, Jan. 30 Cardiac Science,Corporation (Nas...diagnosis,resuscitation, rehabilitation, and infor...e contracts secured by its corporate accounts sale...ndreds,of locations worldwide., (Logo: http:/...

Onmark Launches Integrated Quality(TM) Program to Help Physicians Succeed With National Quality Initiatives Heart of Lancaster and Lancaster Regional Join Highmark Blue Shield Medicare Advantage Network STERIS Corporation Announces Fiscal 2008 Third Quarter Results Minnesotans' Health Stuck in Idle From Inactivity, Unhealthy Eating Anesiva Announces Hiring of Sales Force for FDA-Approved Product Zingo(TM)Cardiac Science Wins Major Corporate AED Deployment Contracts

Sterilized TowerPack Refill System D200

Finntip Wide 10-200ul, Sterile

Finntip 200 Ext (Sterile)

MBP 200MicroPoint Design

Medicine Products:

Sterilized TowerPack Refill System D200 Finntip Wide 10-200ul, Sterile Finntip 200 Ext (Sterile)MBP 200MicroPoint Design

Alexion Commences Dosing in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PN...(ngth of URL please copy and paste into ....),Health